Retina Health Center now accepting patients for clinical trial of new pill for wet age-related macular degeneration

2016-11-08T14:59:05-04:00August 22nd, 2016|Categories: Public Relations|Tags: , , , , , , , , , |

Retina Health Center is now accepting patients for a clinical trial for a new pill, X-82, for the treatment of wet age-related macular degeneration (AMD). Current treatments for wet AMD include three drugs that are injected into the eye that stop the growth of blood vessels, targeting VEGF, a growth factor that contributes to new [...]